Payment of Directors' Fees in Shares and Total Voting Rights
05 May 2010, London, UK, and Cambridge, MA: Cancer drug developer Antisoma plc
(LSE: ASM; USOTC: ATSMY) today announces that three Non-Executive Directors of
Antisoma have taken all or part of their fees for the month ended 30 April 2010
in ordinary shares pursuant to resolutions of the Board of Directors dated 14
September 2004 and subsequently.
The new ordinary shares were issued at a price of 6.92 pence per share, this
being the mid-market closing price on the last trading day of the month (30
April 2010). The relevant Directors have agreed not to dispose of the shares
allotted for a minimum period of one year.
The allotment and total holdings following this allotment are shown below.
+-----------------------+---------+-------------+-
|Director |Allotted |Total holding|Percentage of issued ordinary |
| |06 Apr 10| |shares |
| | | | |
+-----------------------+---------+-------------+-
|Barry Price |27,095 |913,117 |0.15% |
+-----------------------+---------+-------------+-
|Birgit Stattin-Norinder|11,139 |46,935 |0.007% |
+-----------------------+---------+-------------+-
|Michael Lewis |42,148 |339,593 |0.05% |
+-----------------------+---------+-------------+-
Application will be made to the London Stock Exchange and the UK Listing
Authority for the admission of the new ordinary shares of 1p each. The total
number of ordinary shares in the Company in issue and admitted to the Official
List following the above allotments will be 629,256,502.
www.investegate.co.uk/Article.aspx?id=20100505103000H2023
Keine Kauf Empfehlung!!
Wer nicht fähig ist, selber eine Meinung zu bilden und eine Entscheidung zu treffen, darf nicht zur Börse.
